Franziska Bach receives Köln Fortune Stipend
Franziska Bach receives funding through the Köln Fortune program of the University of Cologne » read more
Franziska Bach receives funding through the Köln Fortune program of the University of Cologne » read more
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during analytical treatment interruption. (Nature, 6/15/2016). » read more
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1 (Science, 5/5/2016). » read more
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. (Nature, 3/17/2016). » read more